Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Adding Vyvanse While on Semaglutide: Will Weight Loss Stall or Spike?

A person wrote they’ve been taking semaglutide (a drug used for weight loss) for over a year, dropped a lot of weight, and are close to their goal. They’re about to start a low dose of Vyvanse (a stimulant used for ADHD) and are worried because stimulants commonly reduce appetite and can cause more weight loss. They’re asking what might happen and whether combining the two medicines is safe or likely to cause problems. Semaglutide is the active ingredient in drugs like Ozempic and Wegovy. It acts like a natural gut hormone that tells your brain you’re full and slows how fast food leaves your stomach. That combination reduces appetite and calorie intake, which is why people lose weight on it. Vyvanse (lisdexamfetamine) is a stimulant prescribed for ADHD; it raises levels of certain brain chemicals that increase focus and often lower appetite as a side effect. What we actually know from this note is personal experience, not a clinical trial. People commonly report that stimulants like Vyvanse make them eat less, especially when they first start or the dose goes up. There aren’t big randomized studies that specifically test semaglutide plus stimulants for ADHD, so we don’t have firm numbers on how much extra weight someone will lose when they take both. In short: it’s plausible you’ll see more appetite suppression and possibly additional weight loss, but exactly how much and how fast is uncertain and varies a lot between people. Why this matters is practical. If you’re already near your target weight, extra appetite loss could push you below a healthy weight, lower your energy, or make it harder to get enough nutrients. For someone trying to keep their weight stable, it’s worth planning ahead: regular weigh-ins, monitoring energy and mood, and having strategies to ensure you eat enough (like scheduled meals, calorically dense snacks, or working with a dietitian). If your main concern is the ADHD treatment working well, remember that treating ADHD can improve daily functioning, which may outweigh worries about small additional weight changes. There are some caveats and risks to keep in mind. Both drugs can cause side effects: semaglutide often causes nausea, stomach upset, and sometimes low blood sugar in people on diabetes meds; stimulants can increase heart rate, raise blood pressure, cause sleep trouble, or anxiety. Combining them isn’t universally banned, but doctors should monitor you—especially for too-rapid weight loss, nutritional deficiencies, mood changes, high heart rate, or blood pressure spikes. Don’t stop or start either medication without talking to your prescriber. If you have a history of heart problems, eating disorders, or severe anxiety, bring that up before starting Vyvanse. Bottom line: It’s common to see extra appetite reduction when adding Vyvanse to semaglutide, so plan monitoring and talk to your clinician about dose, nutrition, and safety checks.

Source: r/Semaglutide

Read full story

Back to Riding the pepTIDE